home All News open_in_new Full Article

Basilea: Zweite Meilensteinzahlung über 1,7 Millionen Franken von Lizenzpartner Asahi

Biotechnologie - Das Biopharmaunternehmen Basilea Pharmaceutica erhält erneut eine Umsatzmeilensteinzahlung von einem seiner Lizenzpartner für das Antimykotikum Cresemba.


today 47 h. ago attach_file Other

attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Events
attach_file Other
attach_file Events
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other


ID: 3082662778
Add Watch Country

arrow_drop_down